All SKCCC CTO information has been moved to the SKCCC CTO ONE Site Multidisciplinary Disease Groups |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Multidisciplinary Disease Groups are responsible for:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
For questions
about MDGs, please contact the CTO Senior Director at The MDG is the
first committee that will review an oncology-related study. Note that
retrospective chart reviews and correlative lab trials that will utilize
banked blood and tissue that do not require informed consent are exempt from
MDG review and approval.
|